Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Unity Biotechnology, Inc. - Common Stock
(NQ:
UBX
)
1.340
-0.470 (-25.97%)
Streaming Delayed Price
Updated: 10:41 AM EST, Jan 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
223,527
Open
1.640
Bid (Size)
1.330 (10)
Ask (Size)
1.360 (5)
Prev. Close
1.810
Today's Range
1.280 - 1.640
52wk Range
0.9443 - 2.020
Shares Outstanding
14,601,258
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
UNITY Biotechnology Reports Granting of New Employment Inducement Award
January 07, 2025
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer
January 06, 2025
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
Performance
YTD
+17.54%
+17.54%
1 Month
+11.67%
+11.67%
3 Month
-10.07%
-10.07%
6 Month
-6.29%
-6.29%
1 Year
-29.84%
-29.84%
More News
Read More
UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates
November 04, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
Analyst Ratings for Unity Biotechnology
August 09, 2023
Via
Benzinga
UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024
September 24, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
UNITY Biotechnology to Participate in Upcoming Investor Conferences
August 12, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates
August 06, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
UNITY Biotechnology Reports Granting of New Employment Inducement Award
July 24, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer
July 22, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
UBX Stock Earnings: Unity Biotechnology Beats EPS for Q1 2024
May 14, 2024
Via
InvestorPlace
UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates
May 14, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
April 25, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
April 23, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
April 17, 2024
Via
Benzinga
UBX Stock Earnings: Unity Biotechnology Beats EPS for Q4 2023
April 15, 2024
Via
InvestorPlace
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
April 15, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
March 25, 2024
Via
Benzinga
New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss
February 06, 2024
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
January 19, 2024
Via
Benzinga
UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME
December 12, 2023
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
Unity Biotechnology Upgraded - Analyst Highlights Cash Strength & Execution
November 16, 2023
Via
Benzinga
UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updates
November 13, 2023
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
November 10, 2023
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
Are Longevity Stocks the Next Trillion-Dollar Industry? 3 Anti-Aging Picks
October 17, 2023
Via
InvestorPlace
UNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration
September 27, 2023
From
Unity Biotechnology, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.